ACTRN12607000382471已完成3 期
A multicentre randomised phase III study of low-dose thalidomide, prednisolone and zoledronic acid versus prednisolone and zoledronic acid to assess survival post-ASCT maintenance therapy in patients with multiple myeloma
Australasian Leukaemia and Lymphoma Group0 个研究点目标入组 269 人开始时间: 2007年7月23日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 269
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 17 Years 至 o limit（—）
- 性别
- All
入选标准
- •Diagnosis of multiple myeloma responsive to standard anti-myelomatous therapy • No more than 12 months total prior standard-dose chemotherapy.• No previous high-dose chemotherapy or autologous transplantation procedure.• Eastern Cooperative Oncology Group performance status 0, 1, or 2 • Normal liver and kidney function • =2.0 x 106/kg CD34+ stem cells available for infusion.• No contraindication to the use of any of the study drugs, including known sensitivity to E coli derived preparations.• Written informed consent.
排除标准
- •Patients with monoclonal gammopathy of uncertain significance or indolent multiple myeloma.• Patients with progressive multiple myeloma pre or post-ASCT.• Patients whose general condition makes them unsuitable for intensive treatment • Active infections or other illnesses that would preclude conditioning chemotherapy or maintenance therapy administration or patient compliance.• Pregnant or lactating women.
研究者
相似试验
进行中（未招募）
不适用
Rectal cancer And Pre-operative Induction therapy followed by DedicatedOperatioEUCTR2010-023957-12-ESniversity Medical Center Groningen (UMCG)885
进行中（未招募）
不适用
Rectal cancer And Pre-operative Induction therapy followed by Dedicated OperatioEUCTR2010-023957-12-SIInstitute of Oncology Ljubljana885
进行中（未招募）
不适用
Rectal cancer And Pre-operative Induction therapy followed by DedicatedOperatioEUCTR2010-023957-12-DKniversity Medical Center Groningen (UMCG)885
进行中（未招募）
不适用
Randomized Multicentre Phase III study of short course radiation therapy followed by prolonged pre-operative chemotherapy and surgery in primary high risk rectal cancer compared to standard chemoradiotherapy and surgery - RAPIDOprimary rectal cancer without detectable distant metastasis, but with a high risk to relapse locally or systemically.MedDRA version: 12.1Level: LLTClassification code 10038038Term: Rectal cancerEUCTR2010-023957-12-SEDutch Colorectal Cancer Group885
已完成
3 期
Randomized Multicentre Phase III study of short course radiation therapy followed by prolonged pre-operative chemotherapy and surgery in primary high risk rectal cancer compared to standard chemoradiotherapy and surgery and optional adjuvant chemotherapy (RAPIDO study)rectal cancer10017990NL-OMON47895niversitair Medisch Centrum Groningen361